Navigation Links
Could Cholesterol Treatment Fight Repeat Heart Attack?
Date:11/5/2012

By Randy Dotinga
HealthDay Reporter

MONDAY, Nov. 5 (HealthDay News) -- A biopharmaceutical company is developing a treatment that aims to prevent repeat heart attacks by using a component of "good" cholesterol to clear arteries of dangerous cholesterol buildup.

"We hope what we have is a new mechanism to go after cholesterol in the days or weeks after a heart attack," said Sam Wright, global strategic director of cardiovascular therapeutics at CSL Limited, which is headquartered in Australia.

The research is in the early stages, and it's far from clear if the potential treatment will work. Still, the preliminary findings are positive, said Wright. And they were to be presented Monday at the annual meeting of the American Heart Association in Los Angeles.

According to Wright, up to 20 percent of people who survive a heart attack have another one over the next year. The risk is highest in the first several weeks.

While heart surgeons can often prop open clogged arteries after a heart attack, other arteries can remain blocked, he said. "We'd like to remove the cholesterol from all the arteries and prevent blockades," he said.

In the new study -- which represents the first of three stages of research that drugs must undergo before winning approval in the United States -- researchers gave intravenous doses of a protein from so-called "good" (HDL) cholesterol to 57 healthy volunteers.

The study found that the body quickly began to do a better job of removing "bad" (LDL) cholesterol from cells. While scientists often say that every drug has side effects, the researchers saw no signs of adverse effects related to the treatment.

The treatment appeared to work by boosting the body's ability to dispose of "bad" cholesterol, Wright said. While aspirin and anti-platelet drugs prevent clotting after a heart attack, they don't attack the cholesterol that has built up in artery plaque, the study authors noted.

The researchers are continuing to study the drug in people, and it's unknown if it will actually help reduce the risk of heart attack. Also, it's too early to estimate the cost or determine if it might prevent heart attacks in people with high cholesterol who haven't had a heart attack, Wright said.

Dr. David Brown, a cardiologist and professor of medicine at Stony Brook University Medical Center in New York, predicted that the drug will be expensive. "It also involves processing of human blood, which comes with some risk of spreading infection," he said. "Also, other drugs that increase HDL have not been shown to be of major clinical benefit."

Brown also said it would be unlikely that the drug could be given to anyone with high cholesterol, even those who haven't had heart attacks.

Dr. Gregg Fonarow, a professor of cardiology at University of California, Los Angeles, noted that the treatment is given intravenously, which "could be considered a significant drawback" compared to drugs taken by mouth.

It's unclear how often patients would have to undergo the treatment.

Data and conclusions presented at meetings are typically considered preliminary until published in a peer-reviewed medical journal.

More information

The U.S. National Library of Medicine has details on heart attack.

SOURCES: Sam Wright, Ph.D., global strategic director of cardiovascular therapeutics, CSL Limited, King of Prussia, Pa.; David L. Brown, M.D., cardiologist and professor of medicine, Stony Brook University Medical Center, Stony Brook, N.Y.; Gregg Fonarow, M.D., professor of cardiology, University of California, Los Angeles; Nov. 5, 2012, presentation, American Heart Association annual meeting, Los Angeles


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New research suggests standardized booster seat laws could save lives of children
2. New device could allow your heartbeat to power pacemaker
3. For Many, Superstorm Sandy Could Take Toll on Mental Health
4. Health inequalities could be reduced by more effective health care, says new study
5. Health inequalities could be reduced by more effective healthcare, says new study
6. New findings on mens genes could alter interpretation of PSA test
7. Pinning protein could answer provocative cancer question
8. Feinstein Institute researchers discover that bean used in Chinese food could protect against sepsis
9. Walking to the beat could help patients with Parkinsons disease
10. Study shows breath analysis could help diagnose pulmonary nodules
11. Could Facebook Be Making You Fat?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Could Cholesterol Treatment Fight Repeat Heart Attack?
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... New patients ... to replace their missing teeth can now have them placed by Dr. Manju Kejriwal, ... latest i-CAT® Cone Beam technology to increase the accuracy of each dental implant placement. ...
(Date:3/27/2017)... ... 2017 , ... A study by the founder of the Buckingham Center ... MD, was recently published in the American Journal of Cosmetic Surgery. “The Effects of ... Roy’s study on the use of Electro Lube during the facelift procedure. The journal, ...
(Date:3/27/2017)... ... March 27, 2017 , ... M&S ... Certificate of Conformity for the Smart System® 20/20. CE Certification builds upon M&S's ... standards and specifications such as ANSI, ISO and proven test methods used in ...
(Date:3/27/2017)... and Lake Orion, Michigan (PRWEB) , ... March ... ... weight loss results. The comprehensive weight management program at Women’s Excellence will ... with an initial evaluation and physical exam. The specialists at Women's Excellence ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... organization of nurses and supply chain professionals, will hold their first Northeast Regional ... Analysis in Bundles.” , “Increasingly, supply chain and value analysis professionals have ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... --  Genprex, Inc. , a privately held, clinical-stage biopharmaceutical company developing ... Company,s Chief Operating Officer, is scheduled to present a corporate overview ... Annual Cancer BioPartnering & Investment Forum: Tuesday, March 28, 2017 at ... ... Annual Future Leaders in Biotech Industry – Friday, April 7, 2017 ...
(Date:3/27/2017)... -- Invivotek, LLC, a Genesis Biotechnology Group ® ... contract research organization (CRO), announced the completion of the ... research facility in Hamilton, New Jersey ... source to reduce costs and lessen the CRO facility,s ... Farm follows Invivotek,s recent expansion from a 19,712 square ...
(Date:3/24/2017)... Oregon and PUNE, India , March 24, 2017 /PRNewswire/ ... 2015, and is estimated to reach $2,614 million by 2022, Globally, registering a CAGR ... to generate the highest revenue, and is projected to dominate the market during the ... ... Allied Market Research Logo ...
Breaking Medicine Technology: